FRIMLEY, England, December 12 /PRNewswire/ --

- Approximately 78% of Beta-thalassaemia Patients had Decreases in Cardiac Iron and 90% had Decreases in Liver Iron After Six Months, Interim Data Show(1)

- Study in Sickle Cell Disease (SCD) Patients With Iron Overload Showed Continued Safety and Efficacy Over Two Years(2)

- Safety and Efficacy Demonstrated in Lower-Risk Myelodysplastic Syndromes (MDS) Patients(3)

COPENHAGEN, December 12 /PRNewswire/ --

- Summary: An IND has Been Filed With the FDA for the Fourth Genmab Antibody Developed Under the Company's Collaboration With Roche.

Genmab A/S (OMX: GEN) announced today that an Investigational New Drug application (IND) for a Genmab antibody developed under the company's collaboration with Roche has been filed with the FDA by Roche. Genentech and Roche are collaborating on development of the antibody which selectively blocks the interaction of the OX40 ligand and its receptor. The companies are evaluating the antibody for the treatment of asthma. Genmab will receive a milestone payment from Roche which does not influence Genmab's financial guidance for 2007.

LONDON, December 12 /PRNewswire/ -- PRNewswire, London, December 12 - Mippin makes it easy to find, read and share content from the most popular news and blogs using your mobile internet browser. The service provides quick access to what other people are reading most during the day and with Christmas around the corner, the new Mippin Gift Guide makes it simple to see what's happening this season. Just point your phone's web browser to: http://mippin.com/giftguide to find mobile phone reviews and other gift inspirations right on your mobile phone. See PRNewswire story 1 FEATURE: Mobile Top 10 on the wire or visit http://www.mediapoint.press.net or http://www.prnewswire.co.uk.

ATTN: FEATURES EDITORS

- With Photo

BRUSSELS, Belgium, December 12 /PRNewswire/ --

The Crossroads Institute for medical education today announced it will develop new educational programs for healthcare professionals focused on improving the treatment of women with cardiovascular disease and the prevention of amputation. The announcement was made by the newly formed committee of the Crossroads Educational Research Program (CERP) at the Crossroads Institute in Brussels, Belgium, which is focused on providing the latest in medical education to advance the treatment of patients with cardiac and vascular disease and is supported by an educational grant from Abbott Vascular.

DALLAS, December 12 /PRNewswire/ --

- Kingdom sought trusted vendor for national ID project, e-government rollout to protect 27 million citizens

LONDON, December 11 /PRNewswire/ --

The MS Society has today (Wednesday) spoken out in support of a call for better care for people with multiple sclerosis (MS) following new research that suggests people with neurological conditions are left in an information void.

Results of the Taking Control survey, published jointly by the Neurological Alliance, the Association of the British Pharmaceutical Industry (ABPI) and Ask About Medicines, highlight how the UK healthcare system is failing people with MS by not ensuring access to appropriate information and specialist advice.